JP2021535110A5 - - Google Patents
Info
- Publication number
- JP2021535110A5 JP2021535110A5 JP2021509758A JP2021509758A JP2021535110A5 JP 2021535110 A5 JP2021535110 A5 JP 2021535110A5 JP 2021509758 A JP2021509758 A JP 2021509758A JP 2021509758 A JP2021509758 A JP 2021509758A JP 2021535110 A5 JP2021535110 A5 JP 2021535110A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- group
- alkyl
- composition according
- bcl
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1814207.5A GB201814207D0 (en) | 2018-08-31 | 2018-08-31 | Combination Therapy |
| GB1814207.5 | 2018-08-31 | ||
| GBGB1908225.4A GB201908225D0 (en) | 2019-06-10 | 2019-06-10 | Combination therapy |
| GB1908225.4 | 2019-06-10 | ||
| PCT/EP2019/073212 WO2020043878A1 (en) | 2018-08-31 | 2019-08-30 | Combination therapy |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021535110A JP2021535110A (ja) | 2021-12-16 |
| JP2021535110A5 true JP2021535110A5 (https=) | 2022-08-29 |
| JPWO2020043878A5 JPWO2020043878A5 (https=) | 2022-08-29 |
| JP7590083B2 JP7590083B2 (ja) | 2024-11-26 |
Family
ID=67841060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021509758A Active JP7590083B2 (ja) | 2018-08-31 | 2019-08-30 | 併用療法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20210322564A1 (https=) |
| EP (1) | EP3843748B1 (https=) |
| JP (1) | JP7590083B2 (https=) |
| KR (1) | KR20210054520A (https=) |
| CN (1) | CN112638392B (https=) |
| AU (1) | AU2019332979B2 (https=) |
| BR (1) | BR112021003675A2 (https=) |
| CA (1) | CA3107085A1 (https=) |
| ES (1) | ES3037206T3 (https=) |
| IL (1) | IL280968B2 (https=) |
| MX (1) | MX2021001908A (https=) |
| PH (1) | PH12021550376A1 (https=) |
| SG (1) | SG11202101518QA (https=) |
| UA (1) | UA128954C2 (https=) |
| WO (1) | WO2020043878A1 (https=) |
| ZA (1) | ZA202100467B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7740994B2 (ja) * | 2019-06-10 | 2025-09-17 | アーデーセー セラピューティクス ソシエテ アノニム | 抗ｃｄ１９抗体薬物複合体とｐｉ３ｋ阻害剤又は二次薬剤を含む併用治療 |
| GB202011993D0 (en) | 2020-07-31 | 2020-09-16 | Adc Therapeutics Sa | ANTI-IL 13Ra2 antibodies |
| WO2023274974A1 (en) * | 2021-06-29 | 2023-01-05 | Adc Therapeutics Sa | Combination therapy using antibody-drug conjugates |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| HRP20110498T1 (hr) | 2005-10-07 | 2011-08-31 | Exelixis | Azetidini kao inhibitori mek za liječenje proliferativnih bolesti |
| DK2906298T3 (en) * | 2012-10-12 | 2018-12-17 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| ES2649990T3 (es) | 2012-10-12 | 2018-01-16 | Medimmune Limited | Conjugados de anticuerpos anti-CD22-pirrolobenzodiazepinas |
| GB201506399D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| WO2017160954A1 (en) * | 2016-03-15 | 2017-09-21 | Seattle Genetics, Inc. | Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors |
| IL301786B2 (en) * | 2016-10-28 | 2025-09-01 | Morphosys Ag | Combination of anti-CD19 antibody with BCL-2 inhibitor and their uses |
| CN110869765A (zh) * | 2017-04-20 | 2020-03-06 | Adc治疗有限公司 | 组合疗法 |
| MX2019015042A (es) * | 2017-06-14 | 2020-08-06 | Adc Therapeutics Sa | Regimen de dosificacion. |
-
2019
- 2019-08-30 CN CN201980056828.XA patent/CN112638392B/zh active Active
- 2019-08-30 KR KR1020217006539A patent/KR20210054520A/ko not_active Ceased
- 2019-08-30 UA UAA202100248A patent/UA128954C2/uk unknown
- 2019-08-30 EP EP19762358.0A patent/EP3843748B1/en active Active
- 2019-08-30 MX MX2021001908A patent/MX2021001908A/es unknown
- 2019-08-30 BR BR112021003675-0A patent/BR112021003675A2/pt not_active Application Discontinuation
- 2019-08-30 CA CA3107085A patent/CA3107085A1/en active Pending
- 2019-08-30 AU AU2019332979A patent/AU2019332979B2/en active Active
- 2019-08-30 JP JP2021509758A patent/JP7590083B2/ja active Active
- 2019-08-30 IL IL280968A patent/IL280968B2/en unknown
- 2019-08-30 US US17/271,108 patent/US20210322564A1/en active Pending
- 2019-08-30 ES ES19762358T patent/ES3037206T3/es active Active
- 2019-08-30 WO PCT/EP2019/073212 patent/WO2020043878A1/en not_active Ceased
- 2019-08-30 SG SG11202101518QA patent/SG11202101518QA/en unknown
-
2021
- 2021-01-22 ZA ZA2021/00467A patent/ZA202100467B/en unknown
- 2021-02-23 PH PH12021550376A patent/PH12021550376A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524449A5 (https=) | ||
| JP2021535110A5 (https=) | ||
| JP2022017295A5 (https=) | ||
| JP2018502902A5 (https=) | ||
| JP2023036950A (ja) | 癌治療のための組み合わせ療法 | |
| JP5785157B2 (ja) | Ｐｌｋ１阻害剤および抗腫瘍剤を含む治療組合せ | |
| SI2809657T1 (en) | New therapeutic agents | |
| JP2018516243A5 (https=) | ||
| HRP20181646T2 (hr) | Konjugati pirolobenzodiazepin - anti-psma protutijela | |
| JP2020528880A5 (https=) | ||
| JP2019506403A5 (https=) | ||
| JP2020505433A5 (https=) | ||
| JP2014510729A5 (https=) | ||
| JP2018511628A5 (https=) | ||
| JP2017502994A5 (https=) | ||
| HRP20180945T1 (hr) | Konjugati protutijelo-pirolobenzodiazepin | |
| JP2013518086A5 (https=) | ||
| JP2021530444A5 (https=) | ||
| JP2018525358A5 (https=) | ||
| JP2010523696A5 (https=) | ||
| JP2021533090A5 (https=) | ||
| JP2013511487A (ja) | Ｃｄｃ７阻害剤と抗新生物薬とを含む治療用の組み合わせ | |
| JP2020531414A5 (https=) | ||
| KR20080004495A (ko) | 암을 치료하기 위한 조합물, 방법 및 조성물 | |
| JPWO2019224275A5 (https=) |